Lazard Asset Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Buy
262,486
+46,548
+22% +$461K ﹤0.01% 799
2026
Q1
$1.99M Buy
215,938
+116,700
+118% +$971K ﹤0.01% 893
2025
Q4
$737K Buy
99,238
+5,546
+6% +$38K ﹤0.01% 1242
2025
Q3
$636K Buy
+93,692
New +$634K ﹤0.01% 1276
2025
Q2
Sell
-50,946
Closed -$370K 2551
2025
Q1
$370K Buy
50,946
+7,348
+17% +$57.7K ﹤0.01% 1491
2024
Q4
$349K Buy
43,598
+11,273
+35% +$97.8K ﹤0.01% 1467
2024
Q3
$236K Buy
32,325
+11,251
+53% +$80.4K ﹤0.01% 1568
2024
Q2
$138K Buy
21,074
+9,788
+87% +$73.8K ﹤0.01% 1661
2024
Q1
$106K Sell
11,286
-6,614
-37% -$56.7K ﹤0.01% 1518
2023
Q4
$140K Buy
17,900
+8,803
+97% +$63.9K ﹤0.01% 1524
2023
Q3
$61K Buy
+9,097
New +$74.5K ﹤0.01% 1794
2023
Q1
Sell
-4,249
Closed -$32K 2571
2022
Q4
$32K Buy
+4,249
New +$28.8K ﹤0.01% 1998
2022
Q3
Sell
-4,651
Closed -$25K 2572
2022
Q2
$25K Buy
+4,651
New +$25.1K ﹤0.01% 2078
2021
Q1
Sell
-6,052
Closed -$46K 2039
2020
Q4
$46K Buy
+6,052
New +$53.3K ﹤0.01% 1418

Other funds holding VMD

Lazard Asset Management's VMD Position: Q2 2026 in Review

Lazard Asset Management increased its Viemed Healthcare (VMD) stake by 22% in Q2 2026, buying an estimated $461K and bringing the position to 262,486 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Lazard Asset Management first reported a position in VMD in Q4 2020 and has held it in 14 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Lazard Asset Management held 262,486 shares of Viemed Healthcare worth $2.99M as of Q2 2026.
  • Lazard Asset Management bought 46,548 Viemed Healthcare shares in Q2 2026, an estimated $461K.
  • Viemed Healthcare made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #799 holding.
  • Lazard Asset Management first reported a position in Viemed Healthcare in Q4 2020 and has held it in 14 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.